Chemical exchange-sensitive spin-lock MRI of glucose analog 3-O-methyl- d -glucose in normal and ischemic brain

Abstract

Glucose transport is important for understanding brain glucose metabolism. We studied glucose transport with a presumably non-toxic and non-metabolizable glucose analog, 3-O-methyl-d-glucose, using a chemical exchange-sensitive spin-lock MRI technique at 9.4 Tesla. 3-O-methyl-d-glucose showed comparable chemical exchange properties with d-glucose and 2-deoxy-d-glucose in phantoms, and higher and lower chemical exchange-sensitive spin-lock sensitivity than Glc and 2-deoxy-d-glucose in in vivo experiments, respectively. The changes of the spin-lattice relaxation rate in the rotating frame (ΔR₁ρ) in normal rat brain peaked at ∼15 min after the intravenous injection of 1 g/kg 3-O-methyl-d-glucose and almost maintained a plateau for >1 h. Doses up to 4 g/kg 3-O-methyl-d-glucose were linearly correlated with ΔR₁ρ. In rats with focal ischemic stroke, chemical exchange-sensitive spin-lock with 3-O-methyl-d-glucose injection at 1 h after stroke onset showed reduced ΔR₁ρ in the ischemic core but higher ΔR₁ρ in the peri-core region compared to normal tissue, which progressed into the ischemic core at 3 h after stroke onset. This suggests that the hyper-chemical exchange-sensitive spin-lock region observed at 1 h is the ischemic penumbra at-risk of infarct. In summary, 3-O-methyl-d-glucose-chemical exchange-sensitive spin-lock can be a sensitive MRI technique to probe the glucose transport in normal and ischemic brains.

Keywords

Brain imaging CEST glucose 2-deoxyglucose acute stroke

Introduction

In the brain, the high-energy demand requires continuous delivery of glucose from blood, and the transport of blood glucose by glucose transporters across the blood–brain barrier (BBB) and into individual cells is an essential step for energy metabolism and brain function. Alterations in glucose transporter function and expression can drastically affect brain function, and the glucose transport can become a rate-limiting step for energy metabolism in pathological conditions, such as Alzheimer’s disease, epilepsy, ischemia, and traumatic brain injury.¹ Thus, glucose transport in the brain is important for understanding glucose metabolism in normal and disease states. Studies of disease-altered glucose transport can also lead to new diagnostic methods^2,3 and therapeutic interventions.^4,5

Glucose transport has often been studied with the glucose analogs, 2-deoxy-d-glucose (2DG) and 3-O-methyl-d-glucose (3OMG), which can be transported by the same glucose transporters as regular d-glucose (Glc). In most cells, 2DG can be phosphorylated to 2DG-6-phosphate (2DG6P), which cannot be metabolized further and is trapped in the intracellular space for several hours.^6–8 Thus, with 2DG, both transport- and metabolism-related information can be obtained with a kinetic model. In contrast, 3OMG cannot be metabolized⁹ and can be fully excreted by kidney.⁹ Although detailed studies of its toxicity is lacking, it is generally considered nontoxic¹⁰ and has much less of an effect on the physiology and cerebral function than 2DG.¹¹ Indeed, there were no behavioral effects for rats with injection of 4 g/kg of 3OMG,¹² while a series of observable behavioral responses, such as ataxia and reduced voluntary movement, were observed for 1 g/kg of 2DG, and rats often died with 2–3 g/kg of 2DG.^12,13 Further, compared with 2DG, the glucose transporter affinity of 3OMG is much closer to that of d-glucose.¹⁴ Thus, 3OMG has been a specific and suitable tracer for studying glucose transport.

Previous studies of 2DG and 3OMG have mostly used a radioisotope-labeled compound with PET or autoradiography techniques. The autoradiography method is almost exclusively limited to animal studies and can only be obtained at a single time point due to the requirement of histology. The PET technique has poor spatial resolution, and the radiation exposure limits the scan frequency and excludes certain patient groups. Recent MRI studies showed that the transport and metabolism of non-labeled glucose and analogs may be imaged with chemical exchange-sensitive techniques, including chemical exchange-sensitive spin-lock (CESL) and saturation transfer (CEST) MRI techniques,^15–20 or a variant of CEST.^21,22 For example, CEST with 3OMG injection was used to detect cancerous tissue in mice with xenograph mammary tumors.¹⁰ In these approaches, non-labeled glucose (or analog) is indirectly detected from a reduction of the water signal during an irradiation pulse, induced by the fast chemical exchange between hydroxyl (i.e. −OH group in Figure 1(a)) and water protons. Compared to direct measurements of glucose or analogs by magnetic resonance spectroscopy, the indirect measurement enhances the sensitivity by about two orders of magnitude.^13,19 However, because other physiological perturbations may be induced by the injection and affect the water signal, it is important to evaluate properties and sources of chemical exchange-sensitive MRI signals.

Figure 1.

Conceptual schematics to map 3OMG uptake by CESL-MRI. (a) Normal water signal is reduced when on-resonance spin-lock irradiation is applied (right vs. left), due to intrinsic relaxation mechanisms unrelated to chemical exchange (blue bracket). Addition of glucose analog 3OMG causes further signal decay due to chemical exchange between 3OMG hydroxyl (OH) protons and water hydrogen (H) protons (example indicated by green arrow). (b) Timeline of 3OMG-CESL MRI experiments shows T₁ρ-weighted images acquired before and after injection to generate R₁ρ (=1/T₁ρ) maps. 3OMG uptake is reflected in ΔR₁ρ maps (i.e. R₁ρ changes induced by the 3OMG injection).

Both CESL and CEST measure similar chemical exchange-related signals of introduced glucose or analogs, but a few studies have suggested that CESL has higher sensitivity than CEST.^19,20 Thus, to investigate the feasibility of MRI for examining glucose transport, we measured CESL MRI with intravenous injection of 3OMG in normal and ischemic brains. We first determined the chemical exchange properties of 3OMG in phantoms. In vivo CESL MRI of 3OMG in normal rat brain was compared to that of glucose and 2DG. To evaluate the sensitivity and signal source of in vivo studies, 3OMG-CESL experiments of the dependence on the injection dose and the applied spin-lock power were performed. As a preliminary study, we also evaluated the potential of 3OMG-CESL in acute stroke to classify different ischemic tissues.

Materials and methods

Animal preparation

Male Sprague–Dawley rats weighing 264–385 g were purchased from Charles Rivers Laboratories, Inc, and were studied with approval by the Institutional Animal Care and Use Committee at the University of Pittsburgh in accordance with the National Institutes of Health guide for the care and use of laboratory animals. All procedures were conducted in accordance ARRIVE (Animals in Research: Reporting In Vivo Experiments) guidelines (www.nc3rs.org.uk/arrive-guidelines). Efforts were made to minimize the number of animals used and to ensure that the animals received the highest quality care. The animals were anesthetized with isoflurane (5% for induction and 2% during surgery) in a mixture of O₂ and air gases with the O₂ concentration kept at about 30% throughout the experiment. The right femoral vein was catheterized for the delivery of maintenance fluid and injection of 3OMG, and the femoral artery was catheterized to monitor the arterial blood pressure. In stroke studies, middle cerebral artery occlusion (MCAO) was carried out to induce permanent ischemia in the left hemisphere.²³ After surgery, the isoflurane level was reduced to 1.4–1.5% during MRI scans. The dynamic blood pressure and end-tidal CO₂ were monitored. The rectal temperature was maintained at 37.5 ± 1.0℃ using a feedback-controlled heating pad.

MR experiments

All experiments were performed on a 9.4-T magnet equipped with an actively shielded 12 cm gradient system (Magnex, UK), interfaced to a DirectDrive 2 console (Agilent, Santa Clara, CA, USA). For phantom experiments, a 3.8 cm ID quadrature volume coil (Rapid Biomedical, OH, USA) was used for radiofrequency transmission and detection. For in vivo studies, a detunable volume excitation (6.4 cm diameter) and surface receiver coil combination (2.2 cm diameter) (Nova Medical Inc, MA, USA) was used, and a 1.6 cm ID home-made surface coil was used for spin-lock power-dependent studies to achieve a maximum power of 5200 Hz. In all experiments, B₁ maps were first obtained to determine the transmit power for spin-lock experiments.²⁴ Since the change in CESL signal induced by 3OMG administration is relatively small, it is critical to maintain stable baseline R₁ρ during long experiments. Thus, we performed CESL experiments after waiting for 0.5–1 h for the animal conditions (e.g. body temperature) to be stabilized inside the magnet.

During on-resonance spin-lock, decay of the water signal is determined by T₁ρ, the spin-lattice relaxation time in the rotating frame (Figure 1(a)). Addition of 3OMG increases the relaxation rate R₁ρ ( = 1/T₁ρ) due to chemical exchange-mediated relaxation between its hydroxyl groups and water protons, thus decreasing the signal of T₁ρ-weighted images. R₁ρ at a given spin-lock power of B₁ was measured by varying the spin-lock duration (TSL) and fitting to a monoexponential decay function as

S (γ B_{1}, TSL) = S_{0} \cdot exp [- R_{1} ρ (γ B_{1}) \cdot TSL]

(1)

where S and S₀ are signal intensities measured with and without spin-lock, respectively, and γ is the gyromagnetic ratio. Assuming a two-pool exchange process where the relative population of hydroxyl proton to water proton, p, is much smaller than 1, R₁ρ can be expressed as^25,26

R_{1 ρ} = \frac{p \cdot k_{ex} \cdot δ^{2}}{δ^{2} + γ^{2} B_{1}^{2} + k_{ex}^{2}} + R_{2, 0}

(2)

where k_ex and δ are the exchange rate and chemical shift between protons in water and hydroxyl protons, respectively, and R_2,0 is the transverse relaxation rate of water protons without chemical exchange contributions. Assuming there is no change in k_ex, ΔR₁ρ after the administration of 3OMG can be expressed as

Δ R_{1 ρ} = \frac{Δ p \cdot k_{ex} \cdot δ^{2}}{δ^{2} + γ^{2} B_{1}^{2} + k_{ex}^{2}} + Δ R_{2, 0}

(3)

where the first term indicates the contribution from the increase of the total hydroxyl concentration of 3OMG, and ΔR_2,0 indicates the change of R₂ from all non-chemical exchange-related effects.

Phantom experiments and data analyses

3OMG dissolved in phosphate-buffered saline (PBS) was placed in individual vials, and data from multi-vial phantoms were acquired at 37℃ to characterize various chemical exchange properties—i.e. relative population of hydroxyl to water protons p and exchange rate k_ex between 3OMG hydroxyl and water protons. (i) To study the concentration dependence, 0, 10, 15, 20, and 30 mM of 3OMG were titrated to pH = 7.07, and 0.15 mM of MnCl₂ was added to reduce the T₁ and T₂ of water so that they are closer to in vivo values. (ii) To study the pH-dependence, 20 mM of 3OMG was titrated to pH = 6.3, 6.6, 7.05, and 7.5. No MnCl₂ was added due to the difficulty to control pH.

For all phantoms, T₁ρ-weighted images were measured with single-shot spin-echo echo planar imaging (EPI) for 11 γB₁ values between 125 and 4000 Hz, with TSL from 0 to 200 ms for the concentration-dependent samples and 0 to 1 s for the pH-dependent samples, 64 × 64 matrix size, 4 × 4 cm² field of view (FOV), 5 mm slice thickness, echo time (TE) = 25 ms, and repetition time (TR) = 15 s. Two separate sets of phantoms were prepared, and the data were averaged from the two measurements. At each γB₁ value, R₁ρ was computed from each phantom using equation (1). To obtain pH-dependent exchange parameters, dispersion curves (R₁ρ vs. spin locking power γB₁) were fitted to equation (2) with δ = 1.4 ppm ¹⁹.

In vivo experiments

CESL MRI studies were performed with injection of 3OMG under 1.5% isoflurane anesthesia. Images with different T₁ρ weighting (i.e. different TSL values) were acquired before and after the intravenous injection of 3OMG in 30% weight/volume solution (Figure 1(b)). Specifically, spin-lock MRI images were continuously acquired during a 30–60-min pre-injection and 60–120-min post-injection period. For spin-lock preparation, 50 ms spin-lock irradiation at the desired γB₁ level was sandwiched between an adiabatic half-passage pulse and an inverse adiabatic half-passage pulse (each of 1.5 ms duration).^19,27 Immediately after the spin-lock preparation, MR images were acquired by EPI. Images with (i) TSL = 0 (without average) and (ii) TSL = 50 ms and γB₁ = 500 Hz (three averages) were interleaved for all studies except the spin-lock power-dependent studies (Paradigm 3). In pilot studies (not shown), the temporal signal-to-noise ratio (tSNR) measured with TSL = 0 was about 2–3 times higher than that with TSL = 50 ms; thus, the latter images were averaged three times to improve tSNR of the R₁ρ time series. In Paradigm 3, one image with TSL = 0 and six images with TSL = 50 ms and γB₁ that was varied from 500 Hz to 5200 Hz were interleaved. Images were acquired with a 64 × 64 matrix size, FOV = 32 mm × 32 mm, 2–4 slices with 2 mm thickness, TE = 28 ms and TR = 3 s.

Paradigm 1: A single bolus of 1 g/kg of 3OMG (n = 5 rats) was given to determine the sensitivity and the temporal characteristics of 3OMG-CESL, and its results were compared to data obtained from the same 1 g/kg dose injection of 2DG (n = 4) and Glc (n = 4) in our recent study.¹⁹

Paradigm 2: To determine the dose dependence, a bolus of 1 g/kg 3OMG was injected in about 2 min and repeatedly injected every 30 min, accumulating to 4 g/kg 3OMG (n = 5 rats). CESL images were measured for a total of 2.5 h.

Paradigm 3: One concern is that the CESL signal change is affected by non-chemical exchange effects, such as an increase of the osmolality effect caused by the injection of hypertonic solution, leading to a water shift between blood and extravascular tissue and affecting the tissue R₁ρ. To separate chemical exchange-dependent and -independent R₁ρ contributions (see equation (3)), spin-lock power-dependent T₁ρ studies were performed, since the non-chemical exchange signal should be independent of spin-lock pulse power.¹⁹ For this, a home-built surface coil (1.6 cm diameter) was used to achieve high transmit power.²⁸ Since surface coil excitation induces an inhomogeneous B₁ field, a small region of interest (ROI) was selected in the cortex. To ensure that a similar γB₁ was applied to all animals, the transmit power was adjusted so that the averaged γB₁ during TSL in this small cortical ROI reached the targeted value of about 500, 800, 1280, 2000, 3280, and 5200 Hz. As an “osmolality control”, mannitol was used.¹⁹ Because mannitol cannot be transported across the BBB,²⁹ the osmotic gradient will be sustained longer than that from the injection of 3OMG, because 3OMG can be quickly transported to the extravascular space, and consequently, the osmotic gradient will decline. Thus, for the spin-lock dispersion studies, CESL was measured with a 4 g/kg injection of 3OMG (n = 4) and a smaller 2 g/kg injection of mannitol (n = 4). Due to the high dose, the solution was slowly injected for 8–10 minutes to reduce the impact on animal physiology.

Paradigm 4: In ischemic stroke studies, CESL R₁ρ maps were acquired at about 1 h after the MCAO onset, for a total duration of 10 min—i.e. 2.5 min before to until 7.5 min after an injection of 0.6 g/kg 3OMG (n = 3). ADC maps were acquired with a low b-value of 5 s/mm² applied on one axis and a high b-value of 1200 s/mm² applied on six different directions, at about 1 h and 3 h post-MCAO onset to determine the ischemic lesion and its progression, respectively. For comparison with 3OMG, the same CESL experiments were repeated on MCAO animals with injection of saline (n = 3) at 1 h post-MCAO onset. In this preliminary study, only six animals were studied without randomization or blinding for group allocation.

In vivo data analysis

Data were analyzed with in-house Matlab® programs and STIMULATE software.³⁰ Time series of images with the same spin-lock parameters (i.e. TSL and/or γB₁ value) were first extracted from each run, and time series of R₁ρ maps were calculated by ln (S_TSL=0/S_TSL=50 ms)/50 ms where S_TSL=0 and S_{TSL=50 ms} are the signal intensity of TSL = 0 and 50 ms, respectively. Thus, a time series of R₁ρ with γB₁ = 500 Hz was generated in Paradigms 1, 2, and 4, and six time series of R₁ρ with γB₁ = 500 Hz to 5200 Hz were generated in Paradigm 3.

To obtain statistical maps, the Student’s t-test was performed to compare pre- vs. post-injection images on a pixel-by-pixel basis. In normal rats, baseline pre-injection images were defined as data spanning 30 min before the start of injection, while post-injection images were from data spanning 20–60 min post-injection (Paradigms 1 and 3) or 10–30 min after each individual injection in Paradigm 2. In stroke rats (Paradigm 4), the baseline pre-injection images were defined as data spanning 2.5 min before the start of injection, while post-injection images were from data spanning 2.5–7.5 min post-injection. The R₁ρ change or t-value maps were obtained where a threshold of p < 0.05 and a minimum cluster size of three pixels were applied. A threshold of baseline R₁ρ value of 20 s⁻¹ was additionally applied to exclude pixels with significant partial volume fractions of cerebrospinal fluid (CSF) because ΔR₁ρ can be induced by a change of volume fractions between tissue and CSF which have different R₁ρ values (2.5 s⁻¹ for CSF vs. 23 s⁻¹ for tissue).^19,24

Quantitative analyses were performed in ROIs from the middle of the cortex in normal rats (Paradigms 1–3). In Paradigm 3, the ΔR₁ρ as a function of spin-lock power was fitted to equation (3), also assuming δ = 1.4 ppm. In stroke rats of Paradigm 4, ROIs were selected based on different regions identified from the ADC maps—namely early lesion, recruited lesion, and the contralateral normal tissue. The lesion ROI was defined as the pixels with ADC values ≤77% of the mean value from the contralateral hemisphere. The early lesion ROI was obtained from the ADC map at 1 h after the occlusion, while the recruited lesion ROI was the difference between the early lesion ROI and the later lesion ROI obtained at 3 h. The normal contralateral ROI was a mirror of the early ipsilateral lesion ROI across the midline. Histograms were obtained from all pixels within ROIs, and the time courses were obtained from all pixels passing the CESL statistical threshold within these ROIs. Data are shown as mean ± standard deviation (SD).

Results

Properties of 3OMG-CESL

Figure 2(a) compared the dispersion curve of PBS with that of 3OMG at four different concentrations. Note that the PBS sample has relative high R₁ρ values (>7.5 s⁻¹) with minimal dispersion, because the addition of MnCl₂ increases R_2,0. The increase of R₁ρ due to 3OMG (vs. PBS only) is linearly proportional to the concentration, and a linear fit of the R₁ρ vs. concentration yields an R₁ρ of 0.063 s⁻¹/mM at γB₁ = 500 Hz (Figure 2(b)). Figure 2(c) compared the R₁ρ dispersion curves of 3OMG with four different pH values. For on-resonance spin-lock, the exchange-mediated relaxation rate is maximized at the intermediate exchange regime—i.e. the chemical exchange rate between labile proton and water proton is similar to the difference of their Larmor frequencies.²⁶ The R₁ρ at a γB₁ value of 125 Hz is the highest for the pH = 7.05 phantom (Figure 2(d)); thus, hydroxyl-water proton exchange of 3OMG at pH = 7.05 is close to the intermediate exchange regime. By fitting the R₁ρ dispersion data to equation (2), we determined the exchange rate between water and 3OMG hydroxyl protons to be 4420 s⁻¹ for a pH of 7.05, which is similar to 2DG and Glc.¹⁹

Figure 2.

Chemical exchange properties of 3OMG. (a) R₁ρ dispersions of 0, 10, 15, 20, and 30 mM 3OMG samples with 0.15 mM of MnCl₂ were dissolved in phosphate-buffered saline (PBS) and titrated to pH = 7.07. (b) The difference of R₁ρ (measured at 500 Hz) between 3OMG samples and the PBS-only sample is linearly proportional to the 3OMG concentrations. The best fitted slope is 0.063 s⁻¹/mM. (c) R₁ρ dispersion curves of 20 mM 3OMG in PBS titrated to different pH values. It should be noted that R₁ρ values were small compared to those of concentration phantoms, because no MnCl₂ was added. (d) The k_ex as a function of pH was fitted from equation (2), assuming a chemical shift δ = 1.4 ppm.

In vivo characteristics of 3OMG-CESL were compared to that of Glc and 2DG. Figure 3(a) shows a simple three-compartment model of how Glc, 3OMG and 2DG are transported and metabolized in the brain. Note that 3OMG and 2DG6P cannot be metabolized, while the thick and thin arrows indicate the directionality of transport by glucose transporters in the brain. Because the intravascular component contributes negligibly to CESL R₁ρ,¹⁹ only the addition of extracellular and intracellular hydroxyl groups (i.e. Glc and 2DG and their metabolic products and 3OMG) will contribute to a CESL R₁ρ change. In Figure 3(b), the time course of the R₁ρ change induced by the injection of 1 g/kg 3OMG was compared with that of Glc and 2DG.¹⁹ CESL time courses of Glc, 2DG, and 3OMG can be explained by the transport and metabolic properties of each molecule. R₁ρ of the fully metabolizable Glc peaks at 10–20 min post-injection and returns to baseline after approximately 60 min, while R₁ρ time courses of 2DG and 3OMG have higher peaks and almost remain on a plateau for >60 min, decreasing at much slower rates. At 60 min, the ΔR₁ρ values of 2DG and 3OMG are approximately 85–88% of their peaks.

Figure 3.

In vivo characteristics of intravenously injected 3OMG, Glc and 2DG. (a) Three-compartment schematic illustration of transport and metabolism of Glc, 2DG, and 3OMG in normal brain. Intravascular, extravascular–extracellular, and intracellular pools are considered. Molecules with red label indicate non-metabolizable. (b) Glucose or glucose analogs were intravenously injected into normal rats. Rat brain R₁ρ changes by 1 g/kg administration of d-glucose (Glc, n = 4), 2DG (n = 4) and 3OMG (n = 5) were plotted, where the injection time is indicated by the gray arrow. Glc and 2DG data were adopted from our previous studies.¹⁹ Errors bars indicate standard deviations.

Dose dependence and signal sources of 3OMG-CESL

The dose dependence of 3OMG-CESL was investigated to determine the relation between in vivo R₁ρ change and dose. With four consecutive 1 g/kg 3OMG injections, ΔR₁ρ was elevated in the whole brain for all doses (Figure 4(a)). The time course from the cortical ROI shows a stepwise increase of R₁ρ (Figure 4(b)). This R₁ρ increase is almost linearly proportional to the injection dose (Figure 4(c)) with a slope of 0.32 s⁻¹ per 1 g/kg injection, and this increase of brain 3OMG can be converted to approximately 5.1 mM for each 1 g/kg IV injection, assuming an R₁ρ of 0.063 s⁻¹/mM obtained from the phantom experiments. Another important issue is the effect of 3OMG on physiology. Except for a short period (∼3–5 min) after the onset of injection, in all animals, the blood pressure, cardiac pulsation, and end-tidal CO₂ level remained relatively stable when the cumulated 3OMG dose reached 4 g/kg, suggesting that a high 4 g/kg dose does not interfere with animal physiology significantly. The average mean arterial pressure dipped from 88.7 ± 7.3 to 62.4 ± 8.2 mm Hg during the injection and recovered back to 84.3 ± 6.5 mm Hg at 3–5 min after the onset of injection.

Figure 4.

In vivo dose-dependent 3OMG-CESL. Comparison of the R₁ρ change maps (a) and the time course (b) of R₁ρ change with four consecutive intravenous (IV) injections of 1 g/kg 3OMG every 30 min. The injection periods are indicated by the gray bars. (c) The increase of R₁ρ calculated from middle cortical ROIs shows a linear dependence on the injection dose. The best fitted slope is 0.32 s⁻¹ per 1 g/kg injection. Error bars indicate standard deviations (n = 5).

In vivo R₁ρ change induced by 3OMG can be a combination of chemical exchange-sensitive and -insensitive contributions (see equation (3)). The chemical exchange effect of 3OMG is highly sensitive to the spin-lock power and diminishes at high γB₁, as shown in Figure 2(c). Thus, to separate these two components, spin-lock power-dependent experiments were performed with a high 4 g/kg dose of 3OMG for enhancing the sensitivity (Figure 5(a)). The increase of R₁ρ reached a peak at about 30–40 min after the injection and then decreased slowly. The peak intensity depends upon γB₁ and decreases as γB₁ increases. The averaged ΔR₁ρ from 30 to 60 min post-injection is 1.99 s⁻¹, 1.32 s⁻¹, and 0.77 s⁻¹ for 500 Hz, 2000 Hz, and 5200 Hz, respectively. The ratio of ΔR₁ρ at 500 Hz to that at 2000 Hz is about 1.5. As an osmolality control, non-transportable mannitol was also studied for spin-lock power dependency. Figure 5(b) shows the time course of CESL with injection of 2 g/kg of mannitol, which rises to peak at approximately 10 min post-injection, much faster than that of 3OMG. Also, the magnitude is smaller, and the ΔR₁ρ is almost independent of γB₁, indicating that the source of change originates from non-chemical exchange effects, e.g. the osmolality effect via the ΔR_2,0 term.

Figure 5.

Separation of chemical exchange-sensitive and -insensitive contributions to 3OMG-CESL. Averaged time courses of brain cortical R₁ρ changes were obtained at six different power levels with the IV injection of (a) 4 g/kg 3OMG (note that CESL data were not acquired during the ∼10-min injection period, indicated by the gray bar; n = 5 rats), and (b) 2 g/kg of mannitol (over 3–4 min; n = 4 rats). (c) The change of R₁ρ, averaged from 30 to 60 min after injection as a function of spin-lock power. Unlike mannitol, ΔR₁ρ of 3OMG decreases with spin-lock power, indicating dominant chemical exchange-sensitive contributions. A fitting of in vivo 3OMG-CESL dispersion data to equation (3) (black curve) yielded k_ex = 7480 s⁻¹ and ∼25 mM of 3OMG.

A fitting of the 3OMG-CESL dispersion data (black curve in Figure 5(c)) to equation (3) with a fixed chemical shift of 560 Hz yields Δp = 0.0009, k_ex = 7480 s⁻¹, and ΔR_2,0 = 0.75 s⁻¹. Given that bulk water has 110 M of protons and that each 3OMG molecule has four hydroxyl protons, this increase of hydroxyl concentration (Δp) is equivalent to about 25 mM of 3OMG (=110 × 0.0009/4). Note that the fitted in vivo k_ex is much faster (∼70%) than that of the phantom with pH = 7.05 and similar to that of pH = 7.5. This difference is probably due to the presence of exchange catalysts in vivo.

Stroke imaging with 3OMG-CESL

Figure 6 shows the CESL MRI of stroke rats for the injection of 3OMG (Rat #1) or saline (Rat # 2) at ∼1 h post-MCAO. With 3OMG injection, the ΔR₁ρ map (Figure 6(a)) shows a decrease in R₁ρ within the 1 h ADC-defined ischemic core (green outlines in A–D), where the blood flow should be severely impaired, and thus the delivery and uptake of 3OMG are minimal. Similar R₁ρ-decreasing pixels were detected within the ADC-defined core (green outlines in Figure 6(e) and (f)) in rats with saline injection.

Figure 6.

Permanent MCAO rat brain MRI studies. (a, b) ΔR₁ρ maps acquired with IV injection of 0.6 g/kg 3OMG at 1 h after MCAO onset. In (a), distinct regions of hypo-CESL (blue/purple pixels), normo-CESL (red pixels), and hyper-CESL (yellow pixels) are visible when no ΔR₁ρ threshold is applied. In (b), only pixels with ΔR₁ρ threshold ≥0.4 s⁻¹ are shown. (c, d) ADC maps at 1 and 3 h after the MCAO onset. The early ADC-defined lesion at 1 h (green outline) has expanded at 3 h to include additional regions (purple outlines), representing recruitment to the ischemic lesion during this period. There is excellent overlap between hyper-ΔR₁ρ regions in early (1 h) 3OMG-CESL data and the later (3 h) recruitment of additional pixels to the ADC-defined lesion. ΔR₁ρ map of MCAO rats with saline injection at 1 h only showed a region with decreasing R₁ρ (e), which matches with the ischemic core region from the ADC map (f). (g) ΔR₁ρ histograms from 3OMG-CESL studies at 1 h after MCAO onset (n = 3 rats, averaged) were obtained from all pixels within three ADC-based ROIs—namely, the early lesion, recruited lesion, and contralateral normal regions. Clear distinction of ΔR₁ρ is observed between early lesion, recruited lesion, and the contralateral normal tissue. The averaged ADC values (n = 3) for early and recruited lesion ROIs were 0.46 ± 0.05 and 0.63 ± 0.02 × 10⁻³mm²/s at 1 h, and 0.41 ± 0.05 and 0.47 ± 0.04 × 10⁻³mm²/s at 3 h post-MCAO, respectively. (h) Comparison of time courses of ΔR₁ρ from all pixels passing the statistical threshold in the early lesion, recruited lesion, and contralateral regions.

With 3OMG injection, the mild R₁ρ increase in the contralateral side indicates the uptake of 3OMG in normal tissue. Interestingly, a much larger R₁ρ increase appears adjacent to the ischemic core. These hyper-CESL pixels (yellow in Figure 6(b)) at 1 h match well with the expansion of the ADC lesion from 1 h to 3 h (purple outline in Figure 6(b) and (d)). Since the ischemic lesion evolves rapidly in MCAO for these Sprague–Dawley rats and the ADC lesion at 3 h can be used as a surrogate of the final lesion,^31,32 such recruitment of the lesion retrospectively identifies the at-risk tissue at an earlier time (i.e. 1 h here). The averaged ADC values (n = 3) for the contralateral normal, early lesion, and recruited lesion regions are 0.68 ± 0.02, 0.46 ± 0.05, and 0.63 ± 0.02 × 10⁻³mm²/s at 1 h post-occlusion and 0.67 ± 0.01, 0.41 ± 0.05, and 0.47 ± 0.04 × 10⁻³mm²/s at 3 h post-occlusion, respectively. The histogram of Figure 6(g) obtained from the early lesion, recruited lesion, and contralateral normal tissues shows three distinct groups of hypo-, normo-, and hyper-CESL values with only small overlaps. Further, the ΔR₁ρ time courses demonstrate very different temporal characteristics for three groups of pixels (Figure 6(h)). The rate of increase in R₁ρ for the hyper-CESL region is about three times faster than that of contralateral normal tissues.

Discussion

Source of 3OMG-CESL

A change to the in vivo 3OMG-CESL signal would come mainly from the net change of total 3OMG molecules in the intravascular and extravascular space. While the 3OMG level in the intravascular blood rises to a peak immediately after the bolus injection, the slow time to peak of the ΔR₁ρ time course indicates that the intravascular contribution should be negligible. This may be due to (1) a small arterial vascular volume fraction (about 1%) and (2) suppression of the venous component (with very short T₂) in EPI acquisitions at a relatively long TE.¹⁹ Since 3OMG cannot be metabolized, the signal would only derive from the 3OMG molecules in the intracellular and the extravascular–extracellular space. Nevertheless, since the intravascular 3OMG contribution to ΔR_1ρ may be dependent on imaging readout scheme or magnetic field strength, further studies would be necessary to examine the intravascular signal contribution with flow-crushing gradients or intravascular contrast agents.

Previous studies showed a linear dependence of the blood glucose level versus the brain glucose concentration for a wide plasma glucose range of 4.5–30 mM,^33,34 suggesting that under normal physiological conditions, glucose transport across the BBB is not rate-limiting within this blood glucose range. Our recent glucose-CESL study indicated that the ΔR₁ρ is linearly dependent on the injection dose in the 0.25–1 g/kg range,¹⁹ and this study extended the linear dependence up to 4 g/kg. The ratio of ΔR₁ρ, averaged from 30 to 60 min post-injection at 500 Hz to 2000 Hz, is 1.5 for 3OMG with a 4 g/kg dose, smaller than both Glc and 2DG with a lower 1 g/kg dose (1.75 for Glc and 2.1 for 2DG).¹⁹ When exchange rates are similar, the lower ΔR₁ρ ratio indicates less relative chemical exchange contribution. This suggests that the osmolality effect on ΔR₁ρ does not increase linearly with the injecting dose and that a large injection dose (4 g/kg) may introduce greater relative non-exchange contribution than a lower dose (1 g/kg). Indeed, with a bolus injection of 4 g/kg 3OMG, the non-exchange contribution (i.e. ΔR_2,0) is about 37% of the total ΔR₁ρ measured at 500 Hz. This is much larger than that obtained from a 0.25 g/kg dose of 2DG,¹³ where the non-chemical exchange contribution was estimated to be less than 20% of the total ΔR₁ρ. Thus, a lower injection dose would be preferred for CESL studies to increase the relative contribution of the chemical exchange component.

With a large dose of 3OMG injection, the osmolality of the blood plasma is much higher initially (with no 3OMG in extravascular space), which is expected to attract water from the extravascular space to the intravascular space. This osmolality induced water shift should lead to an increase of R_2,0 as the concentration of macromolecules relative to water in the tissue increases. Note that compared to mannitol which stays in the intravascular space, the transport of 3OMG across the BBB to the brain would reduce this osmolality gradient towards a balance.

Sensitivity of 3OMG-CESL

Our phantom results show that 3OMG has similar chemical exchange properties to Glc and 2DG. For the same g/kg dose, the CESL sensitivity is dependent on its R₁ρ per mM concentration and the molar weight. The R₁ρ per mM concentration of 3OMG (0.063 s⁻¹/mM) is similar to that of Glc (0.066 s⁻¹/mM), but higher than 2DG (0.05 s⁻¹/mM).¹⁹ Also, the hydroxyl water exchange rate (4420 s⁻¹ for pH of 7.05) is very close to that of Glc and 2DG (4500–4700 s⁻¹).¹⁹ Note that the molecular weight of 3OMG is higher than both Glc and 2DG (194 g/mol vs. 180 g/mol and 164 g/mol). Thus, the overall chemical exchange sensitivity of 3OMG is similar to that of Glc and 2DG.

The in vivo sensitivity of CESL is dependent on the net increase of hydroxyl-protons in the extravascular space induced by the administration of Glc or analogs. Both 3OMG and 2DG can be distributed in similar extravascular pools (see Figure 3(a)), but additional contribution from the accumulated intracellular 2DG6P further enhances the CESL response of 2DG compared to 3OMG (Figure 3(b)). Despite the lower CESL sensitivity of 3OMG than 2DG, an important advantage of 3OMG is its less detrimental effect on systemic physiology and brain function.¹¹ Consequently, a high 3OMG dose can be used, even though its maximum dose is undetermined.

The in vivo sensitivity of 3OMG-CESL within 30 min after injection is higher than Glc by approximately 40% (Figure 3(b)), presumably due to the non-metabolizable nature of 3OMG. Indeed, imaging of 3OMG transport in tumors has been recently reported with CEST MRI, showing a much higher CEST signal in tumors after an injection of 3OMG than Glc.¹⁰ Besides offering higher sensitivity, a unique advantage of 3OMG is that it can be applied to certain diseases where the utility of Glc is limited. For example, in diseases where a hyperglycemic condition is detrimental to tissue, such as brain injury and acute stroke,^35–37 injection of glucose may accelerate the lesion growth and should be prevented.

Stroke imaging with 3OMG-CESL

In acute ischemic stroke, one of the most important therapeutic targets is the penumbra—i.e. at-risk tissue that can recover its function with timely restoration of perfusion and will progress to an infarct otherwise. In MRI, the diffusion–perfusion mismatch has been often regarded to roughly approximate the penumbra. Despite the simplicity of this approach, its accuracy remains controversial.³⁸ Figure 6 suggested that CESL can differentiate ischemic core, at-risk, and normal tissues. The decrease of R₁ρ over time in the ischemic core indicated minimal uptake of 3OMG and agreed with previous spin-lock MRI studies of MCAO rats.^39–41 This observation can be explained by the well-known gradual R₂-decreasing effect (i.e. T₂ increase) caused by vasogenic edema. The early hyper-CESL responses at the normal-ADC region adjacent to the ischemic core likely indicated the at-risk tissue, because it progressed to an ischemic core a few hours later. This is similar to animal autoradiography^42–44 and fluorodeoxyglucose PET studies,^45–48 which demonstrated elevated glucose metabolism within the penumbral zone surrounding a focal infarct.

Unlike PET or autoradiography studies, the 3OMG-CESL contrast is indirectly obtained from water and may be caused by differences in glucose transport, tissue pH, the osmolality effect, or BBB permeability between ischemic and normal tissues. Thus, the exact source of the CESL contrast in ischemic brain is still unclear. A dynamic R₁ρ dispersion study, similar to that in Figure 5, may be needed to determine if the contrast is mostly due to the changes in 3OMG transport or is strongly affected by the pH, BBB permeability, and/or the osmolality effect. Nonetheless, our proof-of-principle study showed that the 3OMG-CESL approach can differentiate at-risk tissue from other ischemic and normal tissues in <10 min of scan time. This duration may be further reduced with optimization of the acquisition paradigm. Thus, 3OMG-CESL may provide a valuable diagnostic tool to aid therapeutic decision-making.

Conclusion

We have demonstrated that 3OMG has similar chemical exchange properties as 2DG and Glc and unique advantages relative to 2DG and Glc for in vivo studies—i.e. less toxicity than 2DG and higher sensitivity than Glc. The in vivo 3OMG-CESL signal is mainly caused by the 3OMG transport to the extravascular space but also has a small contribution from the non-chemical exchange effect. In MCAO rats, preliminary results suggest that 3OMG-CESL can stratify different ischemic regions, and identify a region in the ipsilateral brain that will progress to an infarct. This glucose analog can be an attractive molecule to study in disease models that affect glucose transport, especially in applications where the injection of d-glucose may be harmful to the tissue outcome.

Footnotes

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work is supported by NIH grants EB003324, P30-NS076405 and P30-CA047904, and the Institute for Basic Science in Korea (IBS-R015-D1).

Acknowledgement

We thank Kristy Hendrich for maintaining the 9.4 T system.

Declaration of conflicting interests

The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: A patent has been filed by the University of Pittsburgh, and TJ, HM, and SGK are listed as authors on this application.

Authors’ contributions

TJ contributed to the study design, data acquisition, data analysis and interpretation, manuscript drafting and revision. MH took part in the data acquisition, analysis and manuscript revision. PW was involved in study setup, animal surgery, and manuscript revision. SGK was involved in the experimental design, data interpretation, and manuscript revision.

References

Shah

DeSilva

Abbruscato

. The role of glucose transporters in brain disease: diabetes and Alzheimer's disease. Int J Mol Sci 2012; 13: 12629–12655.

Glenn

Kelly

Boscardin

, et al. Energy dysfunction as a predictor of outcome after moderate or severe head injury: indices of oxygen, glucose, and lactate metabolism. J Cereb Blood Flow Metab 2003; 23: 1239–1250.

Noda

Takamatsu

Minoshima

, et al. Determination of kinetic rate constants for 2- F-18 fluoro-2-deoxy-D-glucose and partition coefficient of water in conscious Macaques and alterations in aging or anesthesia examined on parametric images with an anatomic standardization technique. J Cereb Blood Flow Metab 2003; 23: 1441–1447.

Janigro

. Blood-brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res 1999; 37: 223–232.

Klepper

. Impaired glucose transport into the brain: the expanding spectrum of glucose transporter type 1 deficiency syndrome. Curr Opin Neurol 2004; 17: 193–196.

Sokoloff

Reivich

Kennedy

, et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977; 28: 897–916.

Jain

Kalia

Sharma

, et al. Effects of 2-deoxy-D-glucose on glycolysis, proliferation kinetics and radiation response of human cancer cells. Int J Radiat Oncol Biol Phys 1985; 11: 943–950.

Huang

Veech

. Metabolic fluxes between [14C]2-deoxy-D-glucose and [14C]2-deoxy-D-glucose-6-phosphate in brain in vivo. J Neurochem 1985; 44: 567–573.

Jay

Dienel

Cruz

, et al. Metabolic stability of 3-O-methyl-D-glucose in brain and other tissues. J Neurochem 1990; 55: 989–1000.

10.

Rivlin

Tsarfaty

Navon

. Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3-O-methyl-D-glucose. Magn Reson Med 2014; 72: 1375–1380.

11.

Meldrum

Horton

. Cerebral functional effects of 2-deoxy-D-glucose and 3-O-methylglucose in rhesus monkeys. Electroencephalogr Clin Neurophysiol 1973; 35: 59–66.

12.

Miller

Villeneuve

Braun

, et al. Effect of pharmacological doses of 3-0-methyl-D-glucose and 2-deoxy-D-glucose on rat brain glucose and lactate. Stroke 1986; 17: 957–961.

13.

Jin

Mehrens

Wang

, et al. Glucose metabolism-weighted imaging with chemical exchange-sensitive MRI of 2-deoxyglucose (2DG) in brain: sensitivity and biological sources. Neuroimage 2016; 26: 82–90.

14.

Pardridge

Oldendorf

. Kinetics of blood-brain transport of hexoses. Biochim Biophys Acta 1975; 382: 377–392.

15.

Chan

KWY

McMahon

Kato

, et al. Natural D-glucose as a biodegradable MRI contrast agent for detecting cancer. Magn Reson Med 2012; 68: 1764–1773.

16.

Nasrallah

Pages

Kuchel

, et al. Imaging brain deoxyglucose uptake and metabolism by glucoCEST MRI. J Cereb Blood Flow Metab 2013; 33: 1270–1278.

17.

Walker-Samuel

Ramasawmy

Torrealdea

, et al. In vivo imaging of glucose uptake and metabolism in tumors. Nat Med 2013; 19: 1067–1072.

18.

Rivlin

Horev

Tsarfaty

, et al. Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI. Sci Rep 2013; 3: 3045.

19.

Jin

Mehrens

Hendrich

, et al. Mapping brain glucose uptake with chemical exchange-sensitive spin-lock magnetic resonance imaging. J Cereb Blood Flow Metab 2014; 34: 1402–1410.

20.

Spear

, et al. Measurement of regional cerebral glucose uptake by magnetic resonance spin-lock imaging. Magn Reson Imag 2014; 32: 1078–1084.

21.

Chan

Knutsson

, et al. Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer. Magn Reson Med 2015; 74: 1556–1563.

22.

Yadav

Knutsson

, et al. Dynamic glucose-enhanced (DGE) MRI: translation to human scanning and first results in glioma patients. Tomography 2015; 1: 105–114.

23.

Kiozumi

Yoshida

Nakazawa

, et al. Experimental studies of ischemic brain edema: I: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jap J Stroke 1986; 8: 1–8.

24.

Jin

Kim

S-G

. Change of the cerebrospinal fluid volume during brain activation investigated by T1ρ-weighted fMRI. Neuroimage 2010; 51: 1378–1383.

25.

Trott

Palmer

. R-1rho relaxation outside of the fast-exchange limit. J Magn Reson 2002; 154: 157–160.

26.

Jin

Autio

Obata

, et al. Spin-locking versus chemical exchange saturation transfer MRI for investigating chemical exchange process between water and labile metabolite protons. Magn Reson Med 2011; 65: 1448–1460.

27.

Garwood

DelaBarre

. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001; 153: 155–177.

28.

Jin

Kim

. Characterization of non-hemodynamic functional signal measured by spin-lock fMRI. Neuroimage 2013; 78: 385–395.

29.

Thenuwara

Todd

Brian

JEJ

. Effect of mannitol and furosemide on plasma osmolality and brain water. Anesthesiology 2002; 96: 416–421.

30.

Strupp

. Stimulate: A GUI based fMRI analysis software package. Neuroimage 1996; 3: S607.

31.

Bardutzky

Shen

Henninger

, et al. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke 2005; 36: 2000–2005.

32.

Bardutzky

Shen

Bouley

, et al. Perfusion and diffusion imaging in acute focal cerebral ischemia: Temporal vs. spatial resolution. Brain Res 2005; 1043: 155–162.

33.

Choi

Lei

Gruetter

. Effect of deep pentobarbital anesthesia on neurotransmitter metabolism in vivo: on the correlation of total glucose consumption with glutamatergic action. J Cereb Blood Flow Metab 2002; 22: 1343–1351.

34.

Choi

-Y Lee

S-P

Kim

S-G

, et al. In vivo measurements of brain glucose transport using the reversible Michaelis-Menton model and simultaneous measurements of cerebral blood flow changes during hyperglycemia. J Cereb Blood Flow Metab 2001; 21: 653–663.

35.

Capes

Hunt

Malmberg

, et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients – a systematic overview. Stroke 2001; 32: 2426–2432.

36.

Combs

Reuland

Martin

, et al. Glycolytic inhibition by 2-deoxyglucose reduces hyperglycemia-associated mortality and morbidity in the ischemic rat. Stroke 1986; 17: 989–994.

37.

Martini

Kent

. Hyperglycemia in acute ischemic stroke: a vascular perspective. J Cereb Blood Flow Metab 2007; 27: 435–451.

38.

Heiss

Sorensen

. Advances in imaging. Stroke 2009; 40: E313–E314.

39.

Grohn

OHJ

Lukkarinen

Silvennoinen

, et al. Quantitative magnetic resonance imaging assessment of cerebral ischemia in rat using on-resonance T-1 in the rotating frame. Magn Reson Med 1999; 42: 268–276.

40.

Grohn

OHJ

Kettunen

Makela

, et al. Early detection of irreversible cerebral ischemia in the rat using dispersion of the magnetic resonance imaging relaxation time, T1rho. J Cereb Blood Flow Metab 2000; 20: 1457–1466.

41.

Jokivarsi

Niskanen

Michaeli

, et al. Quantitative assessment of water pools by T1rho and T2rho MRI in acute cerebral ischemia of the rat. J Cereb Blood Flow Metab 2009; 29: 206–216.

42.

Ginsberg

Reivich

Giandomenico

, et al. Local glucose utilization in acute focal cerebral ischemia: local dysmetabolism and diaschisis. Neurology 1977; 27: 1042–1048.

43.

Welsh

Greenberg

Jones

, et al. Correlation between glucose utilization and metabolite levels during focal ischemia in cat brain. Stroke 1980; 11: 79–84.

44.

Tanaka

Greenberg

Gonatas

, et al. Regional flow-metabolism couple following middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab 1985; 5: 241–252.

45.

Walberer

Backes

Rueger

, et al. Potential of early F-18-2-fluoro-2-deoxy-D-glucose positron emission tomography for identifying hypoperfusion and predicting fate of tissue in a rat embolic stroke model. Stroke 2012; 43: 193–U359.

46.

Sobrado

Delgado

Fernandez-Valle

, et al. Longitudinal studies of ischemic penumbra by using F-18-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats. Neuroimage 2011; 57: 45–54.

47.

Kuge

Yokota

Tagaya

, et al. Persistent flow-metabolism uncoupling in a primate model of thromboembolic stroke: a PET study. Stroke 2000; 31: 343.

48.

Yuan

Frank

Hong

, et al. Spatiotemporal uptake characteristics of (18) F-2-fluoro-2-deoxy-D-glucose in a rat middle cerebral artery occlusion model. Stroke 2013; 44: 2292–2299.